Horizon Pharma (HZNP) PT Raised to $39 at Cowen
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Horizon Pharma (HZNP) Tops Q3 EPS by 15c, Offers Guidance
November 6, 2019 7:16 AM ESTHorizon Pharma (NASDAQ: HZNP) reported Q3 EPS of $0.64, $0.15 better than the analyst estimate of $0.49. Revenue for the quarter came in at $665.5 million versus the consensus estimate of $329.76 million.
GUIDANCE:
Horizon Pharma sees Q4 2019 revenue of $1.28-1.3 billion, versus the consensus of... More
